Evaluation of Drug Resistance in Patients With Metastatic Breast Cancer

NCT00003253 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

100

Enrollment

INDUSTRY

Sponsor class

Conditions

Breast Cancer

Interventions

DRUG: paclitaxel
OTHER: antitumor drug screening assay

Sponsor

Oncotech